605 related articles for article (PubMed ID: 26842955)
1. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
[TBL] [Abstract][Full Text] [Related]
2. Restoring Wnt6 signaling ameliorates behavioral deficits in MeCP2 T158A mouse model of Rett syndrome.
Hsu WL; Ma YL; Liu YC; Tai DJC; Lee EHY
Sci Rep; 2020 Jan; 10(1):1074. PubMed ID: 31974426
[TBL] [Abstract][Full Text] [Related]
3. Learning and memory and synaptic plasticity are impaired in a mouse model of Rett syndrome.
Moretti P; Levenson JM; Battaglia F; Atkinson R; Teague R; Antalffy B; Armstrong D; Arancio O; Sweatt JD; Zoghbi HY
J Neurosci; 2006 Jan; 26(1):319-27. PubMed ID: 16399702
[TBL] [Abstract][Full Text] [Related]
4. Generation and analysis of the Rett syndrome-associated MeCP2- null rat model.
Zhai W; Hu HX; Le L; Zhuang FF; Wang KZ; Zhao Y; Wang K; Liu XM; Sun D; Wang XY; Kuang SH; Hu KP
Yi Chuan; 2016 Nov; 38(11):1004-1011. PubMed ID: 27867150
[TBL] [Abstract][Full Text] [Related]
5. mGlu
Gogliotti RG; Senter RK; Fisher NM; Adams J; Zamorano R; Walker AG; Blobaum AL; Engers DW; Hopkins CR; Daniels JS; Jones CK; Lindsley CW; Xiang Z; Conn PJ; Niswender CM
Sci Transl Med; 2017 Aug; 9(403):. PubMed ID: 28814546
[TBL] [Abstract][Full Text] [Related]
6. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
7. Cognitive and social functions and growth factors in a mouse model of Rett syndrome.
Schaevitz LR; Moriuchi JM; Nag N; Mellot TJ; Berger-Sweeney J
Physiol Behav; 2010 Jun; 100(3):255-63. PubMed ID: 20045424
[TBL] [Abstract][Full Text] [Related]
8. Dendritic spine pathologies in hippocampal pyramidal neurons from Rett syndrome brain and after expression of Rett-associated MECP2 mutations.
Chapleau CA; Calfa GD; Lane MC; Albertson AJ; Larimore JL; Kudo S; Armstrong DL; Percy AK; Pozzo-Miller L
Neurobiol Dis; 2009 Aug; 35(2):219-33. PubMed ID: 19442733
[TBL] [Abstract][Full Text] [Related]
9. Choline Rescues Behavioural Deficits in a Mouse Model of Rett Syndrome by Modulating Neuronal Plasticity.
Chin EWM; Lim WM; Ma D; Rosales FJ; Goh ELK
Mol Neurobiol; 2019 Jun; 56(6):3882-3896. PubMed ID: 30220058
[TBL] [Abstract][Full Text] [Related]
10. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome.
Asaka Y; Jugloff DG; Zhang L; Eubanks JH; Fitzsimonds RM
Neurobiol Dis; 2006 Jan; 21(1):217-27. PubMed ID: 16087343
[TBL] [Abstract][Full Text] [Related]
11. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
[TBL] [Abstract][Full Text] [Related]
12. RNAi-induced down-regulation of Mecp2 expression in the rat brain.
Jin J; Bao X; Wang H; Pan H; Zhang Y; Wu X
Int J Dev Neurosci; 2008 Aug; 26(5):457-65. PubMed ID: 18396005
[TBL] [Abstract][Full Text] [Related]
13. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
[TBL] [Abstract][Full Text] [Related]
15. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
[TBL] [Abstract][Full Text] [Related]
16. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
17. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
18. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
[TBL] [Abstract][Full Text] [Related]
19. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
[TBL] [Abstract][Full Text] [Related]
20. Impairment of adenosinergic system in Rett syndrome: Novel therapeutic target to boost BDNF signalling.
Miranda-Lourenço C; Duarte ST; Palminha C; Gaspar C; Rodrigues TM; Magalhães-Cardoso T; Rei N; Colino-Oliveira M; Gomes R; Ferreira S; Rosa J; Xapelli S; Armstrong J; García-Cazorla À; Correia-de-Sá P; Sebastião AM; Diógenes MJ
Neurobiol Dis; 2020 Nov; 145():105043. PubMed ID: 32798727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
